UC Santa Barbara named to National Cancer Institute's multi-center nanotechnology collaboration

October 10, 2005

Santa Barbara, California - October 10, 2005 - UC Santa Barbara has been named to collaborate with UCSD and the Burnham Institute, in La Jolla, to apply its acumen in materials science and nanofabrication to the task of creating intelligent nanoplatforms that can deliver payloads of smaller particles to destroy, image or modify tumors, deliver therapies and perform key measurements.

UCSB will receive about $2 million from the National Cancer Institute's grant, a five-year initiative that establishes seven university centers across the country to develop nanotechnology platforms to treat and monitor cancer.

The effort is part of a $144.3 million five-year initiative for nanotechnology research funded by the National Cancer Institute, part of the National Institutes of Health.

Researchers at UCSB will work with chemists at UCSD to make nanoparticles that will be coated with "biolinkers," molecules developed at the Burnham Institute to make the particles attach to specific types of tumor cells.

"This is a wonderful and exceptional opportunity to work with outstanding collaborators, in a rapidly evolving new set of disciplines at the interface of nanoscience and medicine to transform the ways in which we diagnosis and treat cancer," said Evelyn Hu, a professor of electrical and computer engineering and materials, and Co-Director of the California NanoSystems Institute.

The potential of nanotech-based therapeutic delivery systems to enhance the efficacy of cancer treatments is enormous, but such innovation requires innovative inter-disciplinary work. "Critical to the fight against cancer is the ability to bring together the most advanced and creative thinking in engineering, clinical care and research to apply the enormous potential of nanotechnology," said Matthew Tirrell, professor and Dean of the College of Engineering.
-end-


University of California - Santa Barbara

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.